From established players to up-and-coming firms, Canada’s pharmaceutical company landscape is diverse and dynamic. Canadian drug companies are working to discover and develop major innovations amidst an increasingly competitive global landscape. Rising technologies such as artificial intelligence are playing a role in the landscape as well. Read on to learn…
Investor Insight Radiopharm Theranostics represents a promising investment opportunity in the rapidly growing field of radiopharmaceuticals, leveraging its innovative…
China’s Zijin Mining Group (OTC Pink:ZIJMF,SHA:601899) is reportedly in negotiations to acquire a potential controlling interest in Zangge Mining…
Lead prices rode a wave of volatility in 2024 as global economic uncertainty continued to wreak havoc on metals…
Cybercrime is a growing concern, and it’s estimated that the annual cost of fighting cyber crime will reach US$10.5…
Micron Technology (NASDAQ:MU) announced a US$7 billion investment to build a high-bandwidth memory (HBM) chip-packaging facility in Singapore to…
Iron prices started off strong at the beginning of 2024, but have since dropped steeply to two-year lows. Market…
From established players to up-and-coming firms, Canada’s pharmaceutical company landscape is diverse and dynamic. Canadian drug companies are working…
Cobalt prices started 2024 trading at the US$29,151.50 per metric ton level, the highest price point the battery metal…